Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells

Molecular Medicine Reports

Volumn 9, Issue 3, 2014, Pages 1032-1036

  Gao, Liucun ^a   Xie, Huahong ^b   Dong, Lihou ^a   Zou, Jia ^a   Fu, Jie ^a   Gao, Xin ^a   Ou, Lun ^a   Xiang, Shensi ^a   Song, Haifeng ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; E cadherin; Gankyrin; Hypoxia

Indexed keywords

BREAST NEOPLASMS; CADHERINS; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; MCF-7 CELLS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84893857124     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1860     Document Type: Article

References (22)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Onozuka HK, Tsuchihara K and Esumi H: Hypoglycemic/hypoxic condition in vitro mimicking the tumor microenvironment markedly reduced the efficacy of anticancer drugs. Cancer Sci 102: 975-982, 2011.
3. Louie E, Nik S, Chen JS, et al: Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Res 12: R94, 2010.
4. Pouysségur J, Dayan F and Mazure NM: Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441: 437-443, 2006.
5. Harris AL: Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47, 2002.
6. Krzywda S, Brzozowski AM, Higashitsuji H, et al: The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53. J Biol Chem 279: 1541-1545, 2004.
7. Lozano G and Zambetti GP: Gankyrin: an intriguing name for a novel regulator of p53 and RB. Cancer Cell 8: 3-4, 2005.
8. Higashitsuji H, Higashitsuji H, Itoh K, et al: The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell 8: 75-87, 2005.
9. Fu XY, Wang HY, Tan L, Liu SQ, Cao HF and Wu MC: Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance. World J Gastroenterol 8: 638-643, 2002.
10. Ortiz CM, Ito T, Tanaka E, et al: Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance. Int J Cancer 122: 325-332, 2008.
11. Tang S, Yang G, Meng Y, et al: Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer. Cancer Biol Ther 9: 88-95, 2010.
12. Meng Y, He L, Guo X, et al: Gankyrin promotes the proliferation of human pancreatic cancer. Cancer Lett 297: 9-17, 2010.
13. Li J, Knobloch TJ, Kresty LA, et al: Gankyrin, a biomarker for epithelial carcinogenesis, is overexpressed in human oral cancer. Anticancer Res 31: 2683-2692, 2011.
14. Kim YH, Kim JH, Choi YW, et al: Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression. Exp Mol Pathol 94: 360-365, 2012.
15. Zhen C, Chen L, Zhao Q, et al: Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity. Oncogene 32: 3452-3460, 2013.
16. Liu Y, Higashitsuji H, Higashitsuji H, et al: Overexpression of gankyrin in mouse hepatocytes induces hemangioma by suppressing factor inhibiting hypoxia-inducible factor-1 (FIH-1) and activating hypoxia-inducible factor-1. Biochem Biophys Res Commun 432: 22-27, 2013.
17. Liu N, Zhang G, Bi F, et al: RhoC is essential for the metastasis of gastric cancer. J Mol Med (Berl) 85: 1149-1156, 2007.
18. Yang G, Tang SQ, Huang DS, Wang JW, Liu Y and Wang JY: Aplastic anemia transformed into acute myeloblastic leukemia M1 8 years later: a case report. Zhonghua Er Ke Za Zhi 43: 221, 2005 (In Chinese).
19. Fu J, Chen Y, Cao J, et al: p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1alpha pathways. Hepatology 53: 181-192, 2011.
20. Chen J, Imanaka N, Chen J and Griffin JD: Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br J Cancer 102: 351-360, 2010.
21. Zhu J, Sun L, Lin S, et al: BlyS is up-regulated by hypoxia and promotes migration of human breast cancer cells. J Exp Clin Cancer Res 31: 31, 2012.
22. Dong LW, Yang GZ, Pan YF, et al: The oncoprotein p28GANK establishes a positive feedback loop in beta-catenin signaling. Cell Res 21: 1248-1261, 2011.